Radionetics
Radionetics is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
About Radionetics
Radionetics is a company founded in 2023 headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Radionetics develops targeted small-molecule radiopharmaceuticals for precision oncology, applying drug discovery and development expertise against novel cancer targets (including GPCRs) to treat solid tumors. The company advances radiopharmaceutical therapies and has entered a strategic agreement with Lilly.
Explore Radionetics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.